User profiles for Cristian Turato
 | Cristian TuratoDepartment of Medicine, University of Padova Verified email at unipd.it Cited by 1319 |
High-flow nasal cannula oxygen therapy to treat patients with hypoxemic acute respiratory failure consequent to SARS-CoV-2 infection
A Vianello, G Arcaro, B Molena, C Turato, A Sukthi… - Thorax, 2020 - thorax.bmj.com
This observational study aims to assess the outcome and safety of O 2 -therapy by high-flow
nasal cannula (HFNC) in 28 consecutive patients with severe hypoxemic acute respiratory …
nasal cannula (HFNC) in 28 consecutive patients with severe hypoxemic acute respiratory …
SERPINB3 induces epithelial–mesenchymal transition
S Quarta, L Vidalino, C Turato… - The Journal of …, 2010 - Wiley Online Library
Epithelial–mesenchymal transition is believed to facilitate invasion and metastasis formation
of epithelial tumour cells. SERPINB3 is a serine protease inhibitor, physiologically found in …
of epithelial tumour cells. SERPINB3 is a serine protease inhibitor, physiologically found in …
[HTML][HTML] Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells
S Cannito, C Turato, C Paternostro, A Biasiolo… - Oncotarget, 2015 - ncbi.nlm.nih.gov
SERPINB3 is a cysteine-proteases inhibitor up-regulated in a significant number of cirrhotic
patients carrying hepatocellular carcinoma (HCC) and recently proposed as a prognostic …
patients carrying hepatocellular carcinoma (HCC) and recently proposed as a prognostic …
[HTML][HTML] SERPINB3 is associated with TGF-β1 and cytoplasmic β-catenin expression in hepatocellular carcinomas with poor prognosis
Background: Hepatocellular carcinoma (HCC) is one of the most important sanitary
problems for its prevalence and poor prognosis. To date, no information is available on the …
problems for its prevalence and poor prognosis. To date, no information is available on the …
[HTML][HTML] SERPINB3 protects from oxidative damage by chemotherapeutics through inhibition of mitochondrial respiratory complex I
SERPINB3 (SB3) is a serine protease inhibitor overexpressed in several malignancies of
epithelial origin, including primary liver cancer, where it inhibits apoptosis through poorly …
epithelial origin, including primary liver cancer, where it inhibits apoptosis through poorly …
[HTML][HTML] MiR-122 targets SerpinB3 and is involved in sorafenib resistance in hepatocellular carcinoma
The only first-line treatment approved for advanced hepatocellular carcinoma (HCC) is
sorafenib. Since many patients experience drug resistance, the discovery of more effective …
sorafenib. Since many patients experience drug resistance, the discovery of more effective …
[HTML][HTML] Hyaluronated and PEGylated liposomes as a potential drug-delivery strategy to specifically target liver cancer and inflammatory cells
S Cannito, V Bincoletto, C Turato, P Pontisso… - Molecules, 2022 - mdpi.com
Hepatocellular carcinoma (HCC) is the most frequent primary liver cancer and is characterized
by poor clinical outcomes, with the majority of patients not being eligible for curative …
by poor clinical outcomes, with the majority of patients not being eligible for curative …
[HTML][HTML] Oncostatin M is overexpressed in NASH‐related hepatocellular carcinoma and promotes cancer cell invasiveness and angiogenesis
Oncostatin M (OSM) is a pleiotropic cytokine of the interleukin (IL)‐6 family that contributes
to the progression of chronic liver disease. Here we investigated the role of OSM in the …
to the progression of chronic liver disease. Here we investigated the role of OSM in the …
[HTML][HTML] Liver organoids as an in vitro model to study primary liver cancer
S De Siervi, C Turato - International Journal of Molecular Sciences, 2023 - mdpi.com
Primary liver cancers (PLC), including hepatocellular carcinoma (HCC) and cholangiocarcinoma
(CCA), are among the leading causes of cancer-related mortality worldwide. Bi-…
(CCA), are among the leading causes of cancer-related mortality worldwide. Bi-…
[HTML][HTML] SERPINB3 modulates TGF-β expression in chronic liver disease
C Turato, F Calabrese, A Biasiolo, S Quarta… - Laboratory …, 2010 - nature.com
Transforming growth factor-β1 (TGF-β1) is the master cytokine in the pathogenesis of liver
fibrosis. TGF-β1 and extent of fibrosis were correlated recently to the serpin SERPINB3 in …
fibrosis. TGF-β1 and extent of fibrosis were correlated recently to the serpin SERPINB3 in …